Brexit – Preparing for the end of the transition period and beyond

Duration: 60 minutes


If you do not wish to receive any communication from us, you may unsubscribe at any time. Click here to view our privacy policy.

Why watch


PharmaLex experts will provide updates for our UK, EU and international audiences answering queries on the most recent updates and final preparations for the end of the Brexit transition period. Following recent intense negotiations, the EMA and MHRA have recently published revised guidance setting out their position on preparing for the end of the transition period. 

Key Learnings

  •  Import-export and Wholesale distribution
  •  The revised Regulatory framework and associated timelines
  •  How Pharmacovigilance safety information and ICSRs will be handled

A full day of inspirational speakers

Proud to bring inspirational speakers from across the globe.




Martyn Critchley 

Head of Medical Affairs, PharmaLex

Martyn is a Senior Director at PharmaLex UK and has over 30 years experience in the Pharmaceutical industry including 12 years in consultancy.  Martyn is responsible for PharmaLex UK’s pharmacovigilance operations and is part of the global Pharmacovigilance, Epidemiology and Risk Management team within PharmaLex.





Graham Donaldson 

Associate Director, Regulatory Affairs, PharmaLex

Graham is a Director, Regulatory Affairs at PharmaLex UK. Graham has over 15 years experience in pharmaceutical regulatory consultancy. Graham leads PharmaLex’s UK and Ireland Regulatory Centre of Excellence service delivery area. He advises a wide range of companies about their regulatory activities in the UK and Ireland. 


Charley Maxwell

Director QMC, PharmaLex

Charley has recently joined Pharmalex as Director QMC and Senior Consultant.  He joins us with 20 years’ experience working in industry in Pharmaceutical and Device manufacturing and importation.
His background is B.Sc. In Biochemistry and M.Sc. In Pharmaceutical Manufacturing Technology and he has operated as a QP in Ireland since 2018 for sterile and non-sterile manufacture and third country Importation.